Barclays
RXST icon

Barclays’s RxSight RXST Stock Holding History

Barclays’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
21,857
+1,092
+5% +$6.59K ﹤0.01% 4021
2026
Q1 		$128K Sell
20,765
-452,802
-96% -$3.76M ﹤0.01% 3925
2025
Q4 		$4.93M Buy
473,567
+164,804
+53% +$1.65M ﹤0.01% 2226
2025
Q3 		$2.78M Buy
308,763
+234,253
+314% +$2.06M ﹤0.01% 2621
2025
Q2 		$969K Buy
74,510
+19,444
+35% +$292K ﹤0.01% 3357
2025
Q1 		$1.39M Sell
55,066
-9,741
-15% -$289K ﹤0.01% 2909
2024
Q4 		$2.23M Buy
64,807
+6,021
+10% +$272K ﹤0.01% 2803
2024
Q3 		$2.91M Buy
58,786
+46,783
+390% +$2.4M ﹤0.01% 2541
2024
Q2 		$722K Sell
12,003
-13,543
-53% -$774K ﹤0.01% 2796
2024
Q1 		$1.32M Sell
25,546
-18,063
-41% -$887K ﹤0.01% 2904
2023
Q4 		$1.76M Buy
43,609
+34,862
+399% +$1.02M ﹤0.01% 3021
2023
Q3 		$244K Sell
8,747
-319
-4% -$9.51K ﹤0.01% 3204
2023
Q2 		$261K Sell
9,066
-2,956
-25% -$65.8K ﹤0.01% 3115
2023
Q1 		$201K Buy
12,022
+6,493
+117% +$91.7K ﹤0.01% 3792
2022
Q4 		$70.1K Buy
5,529
+4,656
+533% +$56.6K ﹤0.01% 4418
2022
Q3 		$10K Sell
873
-160
-15% -$2.2K ﹤0.01% 4312
2022
Q2 		$15K Sell
1,033
-1,819
-64% -$24K ﹤0.01% 4508
2022
Q1 		$35K Buy
+2,852
New +$34.2K ﹤0.01% 4248

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Barclays's RXST Position: Q2 2026 in Review

Barclays increased its RxSight (RXST) stake by 5.3% in Q2 2026, buying an estimated $6.59K and bringing the position to 21,857 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #4021.

Barclays first reported a position in RXST in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.93M in Q4 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Barclays held 21,857 shares of RxSight worth $105K as of Q2 2026.
  • Barclays bought 1,092 RxSight shares in Q2 2026, an estimated $6.59K.
  • RxSight made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4021 holding.
  • Barclays first reported a position in RxSight in Q1 2022 and has held it in 18 quarters since.
  • Barclays's RxSight position peaked at $4.93M in Q4 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.